0000000000984012
AUTHOR
L. Craxì
Ripartire dall'uomo: il futuro delle Medical Humanities
Medical humanities can be a useful approach to empower trust in the patient-physician relationship and to avoid a strongly biologized approach to medicine. Today we have to face a new challenge: letting Medical Humanities be not only a maid discipline, but a inter-disciplinary subject that will give a new shape to medical courses.
Prioritization of high-cost new drugs for HCV: making sustainability ethical
Hepatitis C virus (HCV) infection is a major health problem worldwide. Chronic HCV infection may in the long run cause cirrhosis, hepatic decompensation and hepatocellular carcinoma, with an ultimate disease burden of at least 350,000 deaths per year worldwide. The new generation of highly effective direct acting antivirals (DAA) to treat HCV infection brings major promises to infected patients in terms of exceedingly high rates of sustained virological response (SVR) but also of tolerability, allowing even the sickest patients to be treated. Even in the face of the excellent safety and efficacy and wide theoretical applicability of these regimens, their introduction is currently facing cos…